Subscribe To Our Free Newsletter |
Pharma major Lupin slides 5% as Q4 earnings miss street expectations
Mumbai-based Lupin posted a 52 percent year-on-year increase in consolidated net profit, reaching Rs 359.43 crore for the January-March quarter of FY24